Next-generation sequencing (NGS) is a massively parallel sequencing technology that can establish the order of nucleotides in a whole genome with scalability, ultra-high throughput, and rapid scale.
DNA pre-sequencing is key to the whole sequencing process since it involves readying the sample for the next sequencing step. NGS is being used more and more in clinical lab work, testing, and illness diagnosis in healthcare all over the world. The lack of adaptable computer tools is a key factor limiting how quickly we can analyze and understand NGS data. People in the industry are working together to combine resources. The aim is to extract useful information from big, complex databases for medical treatments.
Key Growth Drivers and Opportunities
Increased Genome Mapping Programs: Genome mapping is the process of assigning genes to specific regions of chromosomes and determining the relative distances between genes. Genome mapping is driven by programs designed to obtain high-throughput data and helps us understand genetic disorders, evolutionary relationships, and how traits are inherited. Advances in sequencing tech have made genome mapping rapid, more precise, and cost effective.
Increased Applications of Next Generation Sequencing: Labs can sequence whole genomes fast using Next-Generation Sequencing. Deep sequencing of target areas is a good idea. To study gene expression, measure mRNAs, or use RNA sequencing (RNA-Seq) to find new RNA variations and splicing sites. This method helps with thorough transcriptome profiling across different tissues, conditions, or health problems. It also helps find biomarkers and regulatory elements that change gene expression. RNA-Seq also gives info on post-transcriptional changes and non-coding RNAs.
Challenges
Next-generation sequencing demands qualified workers. So, large-scale testing isn’t viable because it calls for great precision and skill. Data analysis complexity also means a need for trained bioinformaticians. Also, keeping protocols and quality consistent keeps being hard across labs. These limits may slow the spread of NGS in clinics and studies.
Innovation and Expansion
QIAseq Kit Cuts NGS Library Prep to 30 Minutes
In July 2023, the launch of the QIAseq Normalizer Kits that give researchers a fast, convenient and cost-effective method to pool different DNA libraries for best-quality results from next-generation sequencing (NGS) runs.
The QIAseq Normalizer Kit speeds up equalizing DNA concentrations across NGS libraries – so-called normalization – to 30 minutes from several hours by ending the need for quantifying DNA libraries using time-intensive and expensive procedures. It is high-throughput with an optimized protocol for parallel normalization of 96 samples, automation-friendly, and works without hazardous chemicals.
Telesis Bio Ships First Automated NGS Plasmid Prep Kit
In May 2023, Telesis Bio announced the first commercial shipment of its BioXp NGS Library Prep kit for plasmid sequencing. Leveraging this new automation capability of the BioXp platform is expected to enable researchers in high-throughput discovery workflows to reduce hands-on time, cost, and steps of NGS Library Preparation, both accelerating their time to answer and reducing barriers to access to Next-Generation Sequencing.
This kit simplifies complicated procedures into an easy, automated process. This change allows for quicker and more scalable genomic studies in synthetic biology and molecular diagnostics.
Inventive Sparks, Expanding Markets
The key players operating the next-generation sequencing (NGS) market include Thermo Fischer Inc., Hoffmann-La Roche Ltd., among others. Global businesses are collaborating to make NGS data analysis and interpretation simpler. They want to find helpful information in complicated genomic data for better medical treatments.
About Author:
Prophecy is a specialized market research, analytics, marketing and business strategy, and solutions company that offer strategic and tactical support to clients for making well-informed business decisions and to identify and achieve high value opportunities in the target business area. Also, we help our client to address business challenges and provide best possible solutions to overcome them and transform their business.
